{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:47:05Z","timestamp":1790801225214,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1010945","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000}}],"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HIV Vaccine Research and Design","award":["P01 AI110657"],"award-info":[{"award-number":["P01 AI110657"]}]},{"name":"HIV Vaccine Research and Design","award":["P01 Al110657"],"award-info":[{"award-number":["P01 Al110657"]}]},{"name":"HIV Vaccine Research and Design","award":["P01 Al110657"],"award-info":[{"award-number":["P01 Al110657"]}]},{"name":"Bill and Melinda Gates Foundation CAVD","award":["OPP1132237"],"award-info":[{"award-number":["OPP1132237"]}]},{"name":"Bill and Melinda Gates Foundation CAVD","award":["INV002022"],"award-info":[{"award-number":["INV002022"]}]},{"name":"Bill and Melinda Gates Foundation CAVD","award":["OPP1146996"],"award-info":[{"award-number":["OPP1146996"]}]},{"name":"Bill and Melinda Gates Foundation CAVD","award":["OPP002916"],"award-info":[{"award-number":["OPP002916"]}]},{"name":"NIH\/NIAID","award":["HHSN272201800004C"],"award-info":[{"award-number":["HHSN272201800004C"]}]},{"name":"the European Union\u2019s Horizon 2020 research and innovation program","award":["681137"],"award-info":[{"award-number":["681137"]}]},{"name":"Netherlands Organization for Scientific Research","award":["Vici fellowship"],"award-info":[{"award-number":["Vici fellowship"]}]},{"name":"AMC","award":["Ph.D. Scholarship"],"award-info":[{"award-number":["Ph.D. Scholarship"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Broadly neutralizing antibodies (bNAbs) have remarkable breadth and potency against most HIV-1 subtypes and are able to prevent HIV-1 infection in animal models. However, bNAbs are extremely difficult to induce by vaccination. Defining the developmental pathways towards neutralization breadth can assist in the design of strategies to elicit protective bNAb responses by vaccination. Here, HIV-1 envelope glycoproteins (Env)-specific IgG<jats:sup>+<\/jats:sup> B cells were isolated at various time points post infection from an HIV-1 infected elite neutralizer to obtain monoclonal antibodies (mAbs). Multiple antibody lineages were isolated targeting distinct epitopes on Env, including the gp120-gp41 interface, CD4-binding site, silent face and V3 region. The mAbs each neutralized a diverse set of HIV-1 strains from different clades indicating that the patient\u2019s remarkable serum breadth and potency might have been the result of a polyclonal mixture rather than a single bNAb lineage. High-resolution cryo-electron microscopy structures of the neutralizing mAbs (NAbs) in complex with an Env trimer generated from the same individual revealed that the NAbs used multiple strategies to neutralize the virus; blocking the receptor binding site, binding to HIV-1 Env N-linked glycans, and disassembly of the trimer. These results show that diverse NAbs can complement each other to achieve a broad and potent neutralizing serum response in HIV-1 infected individuals. Hence, the induction of combinations of moderately broad NAbs might be a viable vaccine strategy to protect against a wide range of circulating HIV-1 viruses.<\/jats:p>","DOI":"10.1371\/journal.ppat.1010945","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T19:15:47Z","timestamp":1668712547000},"page":"e1010945","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-355X","authenticated-orcid":true,"given":"Jelle","family":"van Schooten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schorcht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinaz","family":"Farokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Umotoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom L. G. M.","family":"van den Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dorning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim G.","family":"Rijkhold Meesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham","family":"Ghalaiyini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Torrents de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia C.","family":"Labranche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Stanfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Sok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Ozorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier W.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-8161","authenticated-orcid":true,"given":"Marit J.","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"ppat.1010945.ref001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"X Wei","year":"1995","journal-title":"Nature"},{"key":"ppat.1010945.ref002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"HX Liao","year":"2013","journal-title":"Nature"},{"key":"ppat.1010945.ref003","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"N Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"ppat.1010945.ref004","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/nm.3963","article-title":"Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies","volume":"21","author":"JN Bhiman","year":"2015","journal-title":"Nat Med"},{"key":"ppat.1010945.ref005","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/JVI.06091-11","article-title":"Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity","volume":"86","author":"Z Euler","year":"2012","journal-title":"J Virol"},{"key":"ppat.1010945.ref006","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1128\/JVI.00757-08","article-title":"Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection","volume":"82","author":"EM Bunnik","year":"2008","journal-title":"J Virol"},{"key":"ppat.1010945.ref007","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1128\/JVI.00093-06","article-title":"Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses","volume":"80","author":"SG Deeks","year":"2006","journal-title":"J Virol"},{"key":"ppat.1010945.ref008","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/jvi.71.5.3734-3741.1997","article-title":"Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals","volume":"71","author":"C Moog","year":"1997","journal-title":"J Virol"},{"key":"ppat.1010945.ref009","doi-asserted-by":"crossref","first-page":"e1003738","DOI":"10.1371\/journal.ppat.1003738","article-title":"Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes","volume":"9","author":"CK Wibmer","year":"2013","journal-title":"PLoS Pathog"},{"key":"ppat.1010945.ref010","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/QAD.0b013e32833243e7","article-title":"Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression","volume":"23","author":"MJ van Gils","year":"2009","journal-title":"AIDS"},{"key":"ppat.1010945.ref011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0000000000000106","article-title":"Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection","volume":"28","author":"P Hraber","year":"2014","journal-title":"AIDS"},{"key":"ppat.1010945.ref012","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"D Sok","year":"2018","journal-title":"Nat Immunol"},{"key":"ppat.1010945.ref013","first-page":"15","article-title":"The expanding array of HIV broadly neutralizing antibodies","author":"LE McCoy","year":"2018","journal-title":"Retrovirology"},{"key":"ppat.1010945.ref014","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.immuni.2018.02.013","article-title":"A Neutralizing Antibody Recognizing Primarily N-linked Glycan Targets the Silent Face of the HIV Envelope","volume":"48","author":"T Zhou","year":"2018","journal-title":"Immunity"},{"key":"ppat.1010945.ref015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.immuni.2019.04.014","article-title":"Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope","volume":"50","author":"T Schoofs","year":"2019","journal-title":"Immunity"},{"key":"ppat.1010945.ref016","first-page":"5","article-title":"Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers","author":"AJ Hessell","year":"2009","journal-title":"PLoS Pathog"},{"key":"ppat.1010945.ref017","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"B Moldt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1010945.ref018","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1084\/jem.20132494","article-title":"Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques","volume":"211","author":"M Shingai","year":"2014","journal-title":"J Exp Med"},{"key":"ppat.1010945.ref019","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/14760584.2019.1690458","article-title":"Strategies for inducing effective neutralizing antibody responses against HIV-1","volume":"18","author":"I del Moral-S\u00e1nchez","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"ppat.1010945.ref020","first-page":"12","article-title":"Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort","author":"E Landais","year":"2016","journal-title":"PLoS Pathog"},{"key":"ppat.1010945.ref021","doi-asserted-by":"crossref","first-page":"e0209437","DOI":"10.1371\/journal.pone.0209437","article-title":"Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth","volume":"13","author":"VU Chukwuma","year":"2018","journal-title":"PLoS One"},{"key":"ppat.1010945.ref022","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.1128\/JVI.05363-11","article-title":"Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals.","volume":"85","author":"GD Tomaras","year":"2011","journal-title":"J Virol"},{"key":"ppat.1010945.ref023","first-page":"636","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.","volume":"458","author":"JF Scheid","year":"2009","journal-title":"Nat 2009 4587238"},{"key":"ppat.1010945.ref024","first-page":"92","article-title":"HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes","author":"Z Ditse","year":"2018","journal-title":"J Virol"},{"key":"ppat.1010945.ref025","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","volume":"384","author":"L Corey","year":"2021","journal-title":"N Engl J Med"},{"key":"ppat.1010945.ref026","first-page":"1","article-title":"Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein","volume":"13","author":"J van Schooten","year":"2022","journal-title":"Nat Commun 2022 131"},{"key":"ppat.1010945.ref027","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/651144","article-title":"Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression","volume":"201","author":"Z Euler","year":"2010","journal-title":"J Infect Dis"},{"key":"ppat.1010945.ref028","first-page":"94","article-title":"Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers","author":"A Schorcht","year":"2020","journal-title":"J Virol"},{"key":"ppat.1010945.ref029","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","article-title":"Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1","volume":"46","author":"MK Gorny","year":"2009","journal-title":"Mol Immunol"},{"key":"ppat.1010945.ref030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2012.12.010","article-title":"Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals","volume":"439","author":"R Andrabi","year":"2013","journal-title":"Virology"},{"key":"ppat.1010945.ref031","first-page":"6","article-title":"Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike","author":"JH Lee","year":"2015","journal-title":"Nat Commun"},{"key":"ppat.1010945.ref032","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.immuni.2019.10.008","article-title":"Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability","volume":"51","author":"V Dubrovskaya","year":"2019","journal-title":"Immunity"},{"key":"ppat.1010945.ref033","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1038\/nmicrobiol.2016.199","article-title":"An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability","volume":"2","author":"MJ van Gils","year":"2016","journal-title":"Nat Microbiol"},{"key":"ppat.1010945.ref034","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface","volume":"515","author":"J Huang","year":"2014","journal-title":"Nature"},{"key":"ppat.1010945.ref035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric prefusion HIV-1 Env","volume":"514","author":"M Pancera","year":"2014","journal-title":"Nature"},{"key":"ppat.1010945.ref036","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.celrep.2017.07.077","article-title":"Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization","volume":"20","author":"A Torrents de la Pe\u00f1a","year":"2017","journal-title":"Cell Rep"},{"key":"ppat.1010945.ref037","first-page":"35","article-title":"Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike","author":"R Derking","year":"2021","journal-title":"Cell Rep"},{"key":"ppat.1010945.ref038","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen","volume":"349","author":"JG Jardine","year":"2015","journal-title":"Science (80-)."},{"key":"ppat.1010945.ref039","article-title":"Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1","author":"K Xu","year":"2018","journal-title":"Nat Med"},{"key":"ppat.1010945.ref040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies","volume":"45","author":"JM Steichen","year":"2016","journal-title":"Immunity"},{"key":"ppat.1010945.ref041","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41586-019-1250-z","article-title":"Immunization expands HIV-1 V3-glycan specific B-cells in mice andmacaques","volume":"570","author":"A Escolano","year":"2019","journal-title":"Nature"},{"key":"ppat.1010945.ref042","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1084\/jem.20161160","article-title":"Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo","volume":"214","author":"M Medina-Ram\u00edrez","year":"2017","journal-title":"J Exp Med"},{"key":"ppat.1010945.ref043","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nsmb.3291","article-title":"Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site","volume":"23","author":"HB Gristick","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"ppat.1010945.ref044","first-page":"95","article-title":"Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein","author":"MM van Haaren","year":"2021","journal-title":"J Virol"},{"key":"ppat.1010945.ref045","first-page":"7","article-title":"Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization","author":"HL Turner","year":"2021","journal-title":"Sci Adv"},{"key":"ppat.1010945.ref046","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"D Sok","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1010945.ref047","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"T Tiller","year":"2008","journal-title":"J Immunol Methods"},{"key":"ppat.1010945.ref048","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science (80-)."},{"key":"ppat.1010945.ref049","first-page":"36","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","author":"X Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ppat.1010945.ref050","first-page":"695","article-title":"IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences","volume":"2011","author":"V Giudicelli","year":"2011","journal-title":"Cold Spring Harb Protoc."},{"key":"ppat.1010945.ref051","doi-asserted-by":"crossref","DOI":"10.1109\/GCE.2010.5676129","article-title":"Creating the CIPRES Science Gateway for Inference of Large Phylogenetic Trees","author":"MA Miller","year":"2010"},{"key":"ppat.1010945.ref052","first-page":"10","article-title":"Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence","author":"K Sliepen","year":"2019","journal-title":"Nat Commun"},{"key":"ppat.1010945.ref053","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"DC Montefiori","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ppat.1010945.ref054","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies","volume":"79","author":"M Li","year":"2005","journal-title":"J Virol"},{"key":"ppat.1010945.ref055","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1","volume":"72","author":"EJ Platt","year":"1998","journal-title":"J Virol"},{"key":"ppat.1010945.ref056","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy","volume":"46","author":"X Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1010945.ref057","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2011.09.007","article-title":"Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells","volume":"375","author":"CA Todd","year":"2012","journal-title":"J Immunol Methods"},{"key":"ppat.1010945.ref058","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and Validation of the TZM-bl Assay for Standardized Assessments of Neutralizing Antibodies Against HIV-1","volume":"0","author":"M Sarzotti-Kelsoe","year":"2014","journal-title":"J Immunol Methods"},{"key":"ppat.1010945.ref059","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.","volume":"9","author":"RW Sanders","year":"2013","journal-title":"PLoS Pathog"},{"key":"ppat.1010945.ref060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: The new Leginon system","volume":"151","author":"C Suloway","year":"2005","journal-title":"J Struct Biol"},{"key":"ppat.1010945.ref061","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JVI.03473-14","article-title":"A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene","volume":"89","author":"P Pugach","year":"2015","journal-title":"J Virol"},{"key":"ppat.1010945.ref062","first-page":"7","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","author":"J Zivanov","year":"2018","journal-title":"Elife"},{"key":"ppat.1010945.ref063","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ppat.1010945.ref064","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jsb.2010.03.007","article-title":"Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions","volume":"170","author":"GD Pintilie","year":"2010","journal-title":"J Struct Biol"},{"key":"ppat.1010945.ref065","first-page":"331","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.","volume":"14","author":"SQ Zheng","year":"2017","journal-title":"Nat Methods 2017 144"},{"key":"ppat.1010945.ref066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"K. Zhang","year":"2016","journal-title":"J Struct Biol"},{"key":"ppat.1010945.ref067","first-page":"290","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"A Punjani","year":"2017","journal-title":"Nat Methods 2017 143"},{"key":"ppat.1010945.ref068","doi-asserted-by":"crossref","first-page":"W474","DOI":"10.1093\/nar\/gkw361","article-title":"SAbPred: a structure-based antibody prediction server","volume":"44","author":"J Dunbar","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ppat.1010945.ref069","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"key":"ppat.1010945.ref070","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/pro.3791","article-title":"Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data","volume":"29","author":"A Casa\u00f1al","year":"2020","journal-title":"Protein Sci"},{"key":"ppat.1010945.ref071","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1107\/S2059798319003875","article-title":"Building and rebuilding N-glycans in protein structure models","volume":"75","author":"B van Beusekom","year":"2019","journal-title":"Acta Crystallogr Sect D, Struct Biol"},{"key":"ppat.1010945.ref072","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jmb.2009.07.008","article-title":"Refinement of Protein Structures into Low-Resolution Density Maps using Rosetta","volume":"392","author":"F DiMaio","year":"2009","journal-title":"J Mol Biol"},{"key":"ppat.1010945.ref073","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.str.2018.09.006","article-title":"Automatically Fixing Errors in Glycoprotein Structures with Rosetta","volume":"27","author":"B Frenz","year":"2019","journal-title":"Structure"},{"key":"ppat.1010945.ref074","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"C Williams","year":"2018","journal-title":"Protein Sci"},{"key":"ppat.1010945.ref075","first-page":"943","article-title":"EMRinger: side chain\u2013directed model and map validation for 3D cryo-electron microscopy.","volume":"12","author":"BA Barad","year":"2015","journal-title":"Nat Methods 2015 1210"},{"key":"ppat.1010945.ref076","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of Macromolecular Assemblies from Crystalline State","volume":"372","author":"E Krissinel","year":"2007","journal-title":"J Mol Biol"},{"key":"ppat.1010945.ref077","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Z Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"key":"ppat.1010945.ref078","first-page":"5","article-title":"Structural basis for germline antibody recognition of HIV-1 immunogens.","author":"L Scharf","year":"2016","journal-title":"Elife"},{"key":"ppat.1010945.ref079","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"PD Adams","year":"2010","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"key":"ppat.1010945.ref080","first-page":"2126","article-title":"Coot: model-building tools for molecular graphics.","volume":"60","author":"P Emsley","year":"2004","journal-title":"urn:issn:0907\u20134449"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1010945","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T20:15:49Z","timestamp":1669925749000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010945"}},"subtitle":[],"editor":[{"given":"Katie J.","family":"Doores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1010945","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1010945","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}